The number of PMN-MDSCs is significantly increased in the tumors of HNC, colon cancer, and NSCLC patients, and the combination of serum LOX1 with neutrophil markers allows the detection of PMN-MDSC in tissues [65]. This evidence concerns the gene OLR1 and malignant colon neoplasm.